期刊文献+

胺碘酮 美西律 普罗帕酮对QT离散度影响的临床观察 被引量:3

Clinical Study of Amiodarone, Mexiletine and Propafenone on QT Dispersion
暂未订购
导出
摘要 目的:观察胺碘酮,美西律,普罗帕酮有效治疗室性心律失常前后QT离散度(QTd)的变化。方法:采用随机、单盲的方法,测定3组病人用药前及用药后一周或两周的QTd.QTCd及RR间期.结果:用药前3组的QTd.QTcd及RR间期无显著性差异(P>0.05)。用药后按碘酮组的QTd,QTcd明显降低(QTd37±15ms与21±9ms,QTcd41±17ms与23±10ms.P<0.05),RR间期明显延长;美西律及普罗帕酮组用药前后QTd,QTcd.RR间期无显著性变化(P>0.05)。用药后胺碘酮组的QTd.QTcd显著小于别外两组(QTd21±9ms与35±8ms,37±13ms,QTcd23±16ms与39±11ms,39±14msP<0.05));但RR间期显著长于另两组。结论:治疗室性心律失常有效者胺碘酮降低QT离散度.而美西律,普罗帕酮对QT离散度无显著影响。 objective: To investigate the effects of amiodarone, maxiletine and propafenone on Variation of QT dispersion (QTd) in patients,with ventricular arrhythmias before and after effective treatment. Metbodst: A random, single-blind and respective study as Performed in 59 petieuts. The QTd, QTcd and RR interval were measured before and one or two weeks after the treatwent of amiodarone(n=26). mexiletine (n=20) and propafenone (n=13). Results : No significant differences of QTd, QTcd and RR interval were found in the three groups before drugg tberapy: The QTd and QTcd were obviously decreased in amiodarone group but RR interval,as increased on the contrary (QTd37±15ms vs 21±9ms, QTcd 41±17ms vs 23±10ms, P<0. 05). There were no significant differences of QTD, QTcd and RR interval in the other two groups (P>0. 05); The QTd and QTcd in amiodarone group,ere obviously icwer than that of mexiletine or propafenone group after treatment (QTd 21±9ms vs 35±13ms, 37±13ms, QTcd 23±10ms vs 39±11ms. 39±14ms, P<0. 05) but the RR interval was higher. Conclusion: In the patients with ventricular arrhythmias treated effectively amiodarone decreased QT dispersion, but mexiletine and propafeone hadno obvious influences on QT dispersion.
出处 《镇江医学院学报》 1999年第2期196-197,共2页 Journal of Zhenjiang Medical College
关键词 胺碘酮 美西律 普罗帕酮 QT离散度 心律失常 Amiodarone Mexiletine Propafenone QT dispersion
  • 相关文献

同被引文献23

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:143
  • 3张治德,高旭.胺碘酮治疗急性心肌梗死伴心律失常120例临床观察[J].实用全科医学,2006,4(5):568-568. 被引量:11
  • 4顾权.胺碘酮治疗急性心肌梗死并发恶性室性心律失常41例[J].同济大学学报(医学版),2006,27(4):64-67. 被引量:9
  • 5Siddoway LA. Amiodarone: guidelines for use and monitoring[ J]. Am Fam Physician, 2003,68 ( 11 ) : 2189 - 2196.
  • 6Antman EM,Anbe DJ,Armstrong PW,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J]. Circulation, 2004,110 (5) :588 - 636.
  • 7Morganroth J. Risk factors for the development of proarrhythmic events [ J ]. Am J Cardiol, 1987,59 ( 11 ) : 32E - 37E.
  • 8Nicklas JM, Mckenna WJ, Stewart RA, et al. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy [ J ]. Am Heart J, 1991,122(4 Pt 1 ) : 1016 - 1021.
  • 9Siddoway LA. Amiodarone:guidelines for LISe and monitoring. Am Fam Physician, 2003, 68( 11 ) :2189-2196.
  • 10Antman EM, Anbe DJ, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST elevation miocardial infarction- executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 2004, 110 ( 5 ) : 5881636.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部